🟢 Trulieve Cannabis is trading 5% up today after Q3 revenue topped estimates

Trulieve Cannabis is trading at $11.46, up 5.09%, after reporting Q3 revenue above estimates.

• Q3 revenue was $230 million, with a 64% gross margin and $89 million in adjusted EBITDA.
• The report pointed to low-single-digit sequential revenue growth in Q4, tempering the strong results. The rebound follows the prior session’s 6.03% decline; coverage characterizes the move as investors reassessing earnings. Broader market gains may also support sentiment.